As increased cathepsin B production correlates with microglial activation [48], and induction of glioma apoptosis by microglia-derived cathepsin B has been demonstrated in vitro [49], first steps were undertaken within the frame of the ParvOryx01 study, to assess glioblastoma-associated microglia/macrophage activation state. Here, CTSB is linked to central nervous system cancer.